Rachel C. Peck

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

University Hospitals Bristol NHS Foundation Trust(Current)

Rachel C. Peck is an author at University Hospitals Bristol NHS Foundation Trust specializing in medicine, immunopathology, and durable clinical response.

ORCID

Publications per year

2017–2022

Publications

Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

Peter L. Turecek, Rachel C. Peck, Savita Rangarajan et al. · Thrombosis Research · 2021 · 46 citations · Full text

Medicine, Molecular Medicine, Pathology +16

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019

Tom Bull, Rory McCulloch, Phillip L.R. Nicolson et al. · Journal of Thrombosis and Haemostasis · 2022 · 22 citations · Full text

Medicine, Emergency Medicine, Hematology +13

Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?

Muhammad Bilal Abid, Muhammad Bilal Abid, Rachel C. Peck et al. · Hematological Oncology · 2017 · 19 citations · Full text

Medicine, Immunology, Oncology +10

1–3 of 3